Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.
Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company.
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Basilard BioTech features a technology platform that transforms the rapidly growing cell-based therapies market.
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Loop Medical develops an easy and painless blood collection technology making it accessible to all.
Exo Therapeutics is a small molecule drug discovery and development company.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Casdin Capital has invested in 95 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Casdin Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Genetics. The firm invests across 22 different industry categories.
Among tracked funding rounds, BBOT received $261.0M in a Post Ipo Equity round. Casdin Capital's total known invested capital is $6.8B.
Casdin Capital's average investment size is $71.7M across its portfolio of 95 companies.
Recent Casdin Capital portfolio additions include Function Oncology, Generation Bio, Flare Therapeutics, iVexSol, Vector Biomed. These companies were founded in 2020 or later.